The Microbiome Test from Genetic Analysis AS launched on a new technology platform, GA-map® Dysbiosis Test kit now commercially available on the Luminex MAGPIX® system 2022-02-152022-02-01
Genetic Analysis AS (GA) reports first commercial sales of the enhanced GA-map® Dysbiosis Test version 2 2022-01-282022-01-27
Genetic Analysis AS and Thalys Medical Technology Group enter Microbiome Laboratory Developed Test (LDT) agreement for the Chinese market 2022-01-13
Genetic Analysis awarded important US patent covering a companion diagnostic method for optimising IBS interventions 2021-11-022021-10-28
Genetic Analysis enters a Service Agreement with Eurofins ADME BIOANALYSES – The first CRO to offer the GA-map® Microbiome test 2021-10-19
Genetic Analysis AS (GEAN): First day of trading in Genetic Analysis shares and warrants on Spotlight Stock Market 2021-10-012021-10-01
Genetic Analysis Co-develops HumGut – The world’s first complete database of reference genomes 2021-09-242021-08-05
